A. Ricci et al., EXPRESSION OF DOPAMINE-RECEPTORS IN IMMUNE ORGANS AND CIRCULATING IMMUNE CELLS, Clinical and experimental hypertension, 19(1-2), 1997, pp. 59-71
The existence of dopamine (DA) D-1- and D-2-like receptors in the rat
and pigeon thymus and in human peripheral blood lymphocytes was invest
igated. The selective D-1-like antagonist [H-3]-SCH 23390 was used as
a ligand of DA D-1-like receptors (D-1 and D-5 sites). Pharmacological
analysis suggests that binding of [H-3]-SCH 23390 to sections of thym
us and to human peripheral blood lymphocytes belongs mainly to the dop
amine D-5 receptor subtype. Light microscope autoradiography, performe
d in sections of rat and pigeon thymus, revealed that these receptors
are located primarily in the cortical layer. DA D-2-like receptors (D-
2, D-3 and D-4 sites) were studied in sections of rat thymus and in pe
ripheral blood lymphocytes by using the putative DA D-3 receptor agoni
st [H-3]-7-OH-DPAT as a ligand. Both rat and pigeon thymus and human p
eripheral blood lymphocytes express a putative DA D-3 receptor. These
data are in agreement with recent molecular biology studies performed
in human peripheral blood lymphocytes. The demonstration of different
subtypes of DA receptors in a primary immune organ such as the thymus
and in circulating immune cells supports the hypothesis of an involvem
ent of DA in the control of immune function.